Veterinary Stereotactic Radiosurgery System Market would rocket up to USD 662.48 million by 2029

Veterinary Stereotactic Radiosurgery System Market Analysis and Size
Stereotactic radiation therapy (SRT) is a method used to deliver a curative dose of external beam radiation therapy. With rapid dose drop-off and precision radiation targeting, this treatment enables for very high doses of radiation to be given without increasing the toxicity to adjacent normal tissues. By altering DNA, this treatment destroys cancer cells or slows their proliferation. The market is expected to be further fueled by elements including government initiatives, rising investments in the veterinary healthcare sector, and quickening technology breakthroughs in noninvasive SRS systems.

Data Bridge Market Research analyses that the veterinary stereotactic radiosurgery system market which was USD 439.94 million in 2021, would rocket up to USD 662.48 million by 2029, and is expected to undergo a CAGR of 5.25% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Read More:
https://www.databridgemarketresearch.com/reports/global-veterinary-stereotactic-radiosurgery-system-market

Market Definition

Veterinary stereotactic radiosurgery (SRS) treats cancers and other health issues in the neck, lungs, brain, liver, spine, and other areas of the body by using a number of finely focused radiation beams. During the procedure, no incisions are made. Instead, stereotactic radiosurgery makes use of 3D imaging to concentrate high radiation doses on the afflicted spot while minimising damage to the healthy tissue around it.

Veterinary Stereotactic Radiosurgery System Market Dynamics
Drivers

Rise in pet population
The primary factor promoting business growth is the expanding use of stereotactic radiosurgery system (SRS) for the treatment of cancer in pets along with an increase in the pet population. The market is expanding thanks to the widely favourable adoption of frameless stereotactic radiosurgery for the treatment of cerebral tumefaction in dogs with favourable clinical outcomes.

Rise in animal healthcare industry
Other factors that are presumed to aid the syndicate include administrative measures, rising costs in the animal healthcare industry, and accelerated technical advancements in non-invasive SRS orderliness.

Opportunities

Increase in the number of research and development activities
The primary factor driving growth for the worldwide veterinary stereotactic radiosurgery system market is the increasing need for stereotactic radiosurgery to treat dogs with cancer.

The growing number of pets afflicted by various cancers in both established and developing nations could be another element in the future that generates profitable revenue-generating prospects for market participants.

Restraints/Challenges

On the other hand, the high cost associated with surgeries will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the market.

This veterinary stereotactic radiosurgery system market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the veterinary stereotactic radiosurgery system market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Some of the major players operating in the veterinary stereotactic radiosurgery system market are:

PetCure Oncology (U.S.)
Varian Medical Systems, Inc. (U.S.)
Accuray Incorporated (U.S.)
BD (U.S.)
C. R. Bard, Inc. (U.S.)
Eckert & Ziegler (Germany)
Elekta (Sweden)
Hitachi, Ltd. (Japan)
IntraOp Medical, Inc. (U.S.)
Ion Beam Applications SA (Belgium)
Isoray, Inc. (U.S.)
Mevion Medical Systems (U.S.)

More Links:

https://dbmrbuisness.blogspot.com/2023/08/global-scientific-data-management.html

https://dbmrbuisness.blogspot.com/2023/08/global-ngs-based-rna-sequencing-market.html

https://dbmrbuisness.blogspot.com/2023/08/global-meningitis-treatment-market.html

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.